Log in to your Inderes Free account to see all free content on this page.
Stayble Therapeutics
0.17 SEK
-2.47 %
Less than 1K followers
STABL
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Stayble Therapeutics
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| EBITDA | -2.3 | -3.2 | -12.8 | -2.0 | -1.9 | -1.5 | ||
| EBIT | -2.3 | -3.2 | -12.8 | -2.0 | -1.9 | -1.5 | -1.5 | -6.9 |
| EBIT-% | ||||||||
| Profit before taxes | -2.3 | -3.0 | -12.4 | -2.0 | -1.9 | -1.5 | -1.5 | -6.9 |
| Net income | -2.3 | -3.0 | -12.4 | -2.0 | -1.9 | -1.5 | -1.5 | -6.9 |
Login required
This content is only available for logged in users